APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Vaccines

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

Selected research

Market Analysis & Forecast

Global Swine Vaccines Market Analysis and Forecast 2026-2032

26 December 2025209 pages

Choose your research edition.

Industry ResearchSwine Vaccines Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Vaccines Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Swine Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Vaccines Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Vaccines Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

Read the full market overview

China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.

This report presents an overview of global market for Swine Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Swine Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Swine Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Swine Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Swine Vaccines sales, projected growth trends, production technology, application and end-user industry.

Swine Vaccines Segment by Company

Merck

Boehringer Ingelheim

Jinyu Bio-Technology

CAHIC

Tecon

Zoetis

Ceva

Hile Bio

Chopper Biology

WINSUN

Hipra

Ringpu Biology

ChengDu Tecbond

DHN

CAVAC

Virbac

HVRI

Bioveta

Swine Vaccines Segment by Type

CSF Vaccines

FMD Vaccines

Porcine Circovirus Vaccines

PRRS Vaccines

Others

Swine Vaccines Segment by Application

Government Tender

Market Sales

Swine Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Swine Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Swine Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CSF Vaccines Major Manufacturers Table 3. FMD Vaccines Major Manufacturers Table 4. Porcine Circovirus Vaccines Major Manufacturers Table 5. PRRS Vaccines Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Swine Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Government Tender Major Manufacturers Table 9. Market Sales Major Manufacturers Table 10. Swine Vaccines Industry Trends Table 11. Swine Vaccines Industry Drivers Table 12. Swine Vaccines Industry Opportunities and Challenges Table 13. Swine Vaccines Industry Restraints Table 14. Global Swine Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Swine Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Swine Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Swine Vaccines Revenue Market Share by Region (2021-2026) Table 18. Global Swine Vaccines Revenue Market Share by Region (2027-2032) Table 19. Global Swine Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 20. Global Swine Vaccines Sales by Region (2021-2026) & (M Doses) Table 21. Global Swine Vaccines Sales by Region (2027-2032) & (M Doses) Table 22. Global Swine Vaccines Sales Market Share by Region (2021-2026) Table 23. Global Swine Vaccines Sales Market Share by Region (2027-2032) Table 24. Global Swine Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Swine Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Swine Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Swine Vaccines Sales Market Share by Manufacturers (2021-2026) Table 28. Global Swine Vaccines Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 29. Global Swine Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Swine Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Swine Vaccines Manufacturers, Product Type & Application Table 32. Global Swine Vaccines Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Swine Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Swine Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Swine Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Swine Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Swine Vaccines Revenue Market Share by Type (2021-2026) Table 39. Global Swine Vaccines Revenue Market Share by Type (2027-2032) Table 40. Global Swine Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 41. Global Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 42. Global Swine Vaccines Sales by Type (2027-2032) & (M Doses) Table 43. Global Swine Vaccines Sales Market Share by Type (2021-2026) Table 44. Global Swine Vaccines Sales Market Share by Type (2027-2032) Table 45. Global Swine Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 46. Global Swine Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 47. Global Swine Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Swine Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Swine Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Swine Vaccines Revenue Market Share by Application (2021-2026) Table 51. Global Swine Vaccines Revenue Market Share by Application (2027-2032) Table 52. Global Swine Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 53. Global Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 54. Global Swine Vaccines Sales by Application (2027-2032) & (M Doses) Table 55. Global Swine Vaccines Sales Market Share by Application (2021-2026) Table 56. Global Swine Vaccines Sales Market Share by Application (2027-2032) Table 57. Global Swine Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 58. Global Swine Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 59. Merck Company Information Table 60. Merck Business Overview Table 61. Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 62. Merck Swine Vaccines Product Portfolio Table 63. Merck Recent Development Table 64. Boehringer Ingelheim Company Information Table 65. Boehringer Ingelheim Business Overview Table 66. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 67. Boehringer Ingelheim Swine Vaccines Product Portfolio Table 68. Boehringer Ingelheim Recent Development Table 69. Jinyu Bio-Technology Company Information Table 70. Jinyu Bio-Technology Business Overview Table 71. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 72. Jinyu Bio-Technology Swine Vaccines Product Portfolio Table 73. Jinyu Bio-Technology Recent Development Table 74. CAHIC Company Information Table 75. CAHIC Business Overview Table 76. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 77. CAHIC Swine Vaccines Product Portfolio Table 78. CAHIC Recent Development Table 79. Tecon Company Information Table 80. Tecon Business Overview Table 81. Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 82. Tecon Swine Vaccines Product Portfolio Table 83. Tecon Recent Development Table 84. Zoetis Company Information Table 85. Zoetis Business Overview Table 86. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 87. Zoetis Swine Vaccines Product Portfolio Table 88. Zoetis Recent Development Table 89. Ceva Company Information Table 90. Ceva Business Overview Table 91. Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 92. Ceva Swine Vaccines Product Portfolio Table 93. Ceva Recent Development Table 94. Hile Bio Company Information Table 95. Hile Bio Business Overview Table 96. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 97. Hile Bio Swine Vaccines Product Portfolio Table 98. Hile Bio Recent Development Table 99. Chopper Biology Company Information Table 100. Chopper Biology Business Overview Table 101. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 102. Chopper Biology Swine Vaccines Product Portfolio Table 103. Chopper Biology Recent Development Table 104. WINSUN Company Information Table 105. WINSUN Business Overview Table 106. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 107. WINSUN Swine Vaccines Product Portfolio Table 108. WINSUN Recent Development Table 109. Hipra Company Information Table 110. Hipra Business Overview Table 111. Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 112. Hipra Swine Vaccines Product Portfolio Table 113. Hipra Recent Development Table 114. Ringpu Biology Company Information Table 115. Ringpu Biology Business Overview Table 116. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 117. Ringpu Biology Swine Vaccines Product Portfolio Table 118. Ringpu Biology Recent Development Table 119. ChengDu Tecbond Company Information Table 120. ChengDu Tecbond Business Overview Table 121. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 122. ChengDu Tecbond Swine Vaccines Product Portfolio Table 123. ChengDu Tecbond Recent Development Table 124. DHN Company Information Table 125. DHN Business Overview Table 126. DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 127. DHN Swine Vaccines Product Portfolio Table 128. DHN Recent Development Table 129. CAVAC Company Information Table 130. CAVAC Business Overview Table 131. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 132. CAVAC Swine Vaccines Product Portfolio Table 133. CAVAC Recent Development Table 134. Virbac Company Information Table 135. Virbac Business Overview Table 136. Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 137. Virbac Swine Vaccines Product Portfolio Table 138. Virbac Recent Development Table 139. HVRI Company Information Table 140. HVRI Business Overview Table 141. HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 142. HVRI Swine Vaccines Product Portfolio Table 143. HVRI Recent Development Table 144. Bioveta Company Information Table 145. Bioveta Business Overview Table 146. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 147. Bioveta Swine Vaccines Product Portfolio Table 148. Bioveta Recent Development Table 149. North America Swine Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 150. North America Swine Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 151. North America Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 152. North America Swine Vaccines Sales by Type (2027-2032) & (M Doses) Table 153. North America Swine Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 154. North America Swine Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 155. North America Swine Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 156. North America Swine Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 157. North America Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 158. North America Swine Vaccines Sales by Application (2027-2032) & (M Doses) Table 159. North America Swine Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 160. North America Swine Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 161. North America Swine Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. North America Swine Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. North America Swine Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. North America Swine Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 165. North America Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 166. North America Swine Vaccines Sales by Country (2027-2032) & (M Doses) Table 167. North America Swine Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 168. North America Swine Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 169. United States Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 170. Canada Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 171. Mexico Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 172. Europe Swine Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 173. Europe Swine Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 174. Europe Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 175. Europe Swine Vaccines Sales by Type (2027-2032) & (M Doses) Table 176. Europe Swine Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 177. Europe Swine Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 178. Europe Swine Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 179. Europe Swine Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 180. Europe Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 181. Europe Swine Vaccines Sales by Application (2027-2032) & (M Doses) Table 182. Europe Swine Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 183. Europe Swine Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 184. Europe Swine Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Europe Swine Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Europe Swine Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Europe Swine Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 188. Europe Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 189. Europe Swine Vaccines Sales by Country (2027-2032) & (M Doses) Table 190. Europe Swine Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 191. Europe Swine Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 192. Germany Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 193. France Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 194. U.K. Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 195. Italy Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 196. Russia Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 197. Spain Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 198. Netherlands Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 199. Switzerland Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 200. Sweden Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 201. Poland Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 202. China Swine Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 203. China Swine Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 204. China Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 205. China Swine Vaccines Sales by Type (2027-2032) & (M Doses) Table 206. China Swine Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 207. China Swine Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 208. China Swine Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 209. China Swine Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 210. China Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 211. China Swine Vaccines Sales by Application (2027-2032) & (M Doses) Table 212. China Swine Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 213. China Swine Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 214. Asia Swine Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 215. Asia Swine Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 216. Asia Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 217. Asia Swine Vaccines Sales by Type (2027-2032) & (M Doses) Table 218. Asia Swine Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 219. Asia Swine Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 220. Asia Swine Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 221. Asia Swine Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 222. Asia Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 223. Asia Swine Vaccines Sales by Application (2027-2032) & (M Doses) Table 224. Asia Swine Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 225. Asia Swine Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 226. Asia Swine Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. Asia Swine Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. Asia Swine Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. Asia Swine Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 230. Asia Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 231. Asia Swine Vaccines Sales by Country (2027-2032) & (M Doses) Table 232. Asia Swine Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 233. Asia Swine Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 234. Japan Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 235. South Korea Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 236. India Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 237. Australia Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 238. Taiwan Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 239. Southeast Asia Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 240. SAMEA Swine Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 241. SAMEA Swine Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 242. SAMEA Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 243. SAMEA Swine Vaccines Sales by Type (2027-2032) & (M Doses) Table 244. SAMEA Swine Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 245. SAMEA Swine Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 246. SAMEA Swine Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 247. SAMEA Swine Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 248. SAMEA Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 249. SAMEA Swine Vaccines Sales by Application (2027-2032) & (M Doses) Table 250. SAMEA Swine Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 251. SAMEA Swine Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 252. SAMEA Swine Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 253. SAMEA Swine Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 254. SAMEA Swine Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 255. SAMEA Swine Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 256. SAMEA Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 257. SAMEA Swine Vaccines Sales by Country (2027-2032) & (M Doses) Table 258. SAMEA Swine Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 259. SAMEA Swine Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 260. Brazil Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 261. Argentina Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 262. Chile Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 263. Colombia Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 264. Peru Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 265. Saudi Arabia Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 266. Israel Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 267. UAE Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 268. Turkey Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 269. Iran Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 270. Egypt Swine Vaccines Revenue (2021-2032) & (US$ Million) Table 271. Key Raw Materials Table 272. Raw Materials Key Suppliers Table 273. Swine Vaccines Distributors List Table 274. Swine Vaccines Customers List Table 275. Research Programs/Design for This Report Table 276. Authors List of This Report Table 277. Secondary Sources Table 278. Primary Sources List of Figures Figure 1. Swine Vaccines Image Figure 2. Global Swine Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. CSF Vaccines Image Figure 5. FMD Vaccines Image Figure 6. Porcine Circovirus Vaccines Image Figure 7. PRRS Vaccines Image Figure 8. Others Image Figure 9. Global Swine Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Swine Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 11. Government Tender Image Figure 12. Market Sales Image Figure 13. Global Swine Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Swine Vaccines Revenue (2021-2032) & (US$ Million) Figure 15. Global Swine Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Swine Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Swine Vaccines Revenue Market Share by Region (2021-2032) Figure 18. Global Swine Vaccines Sales (2021-2032) & (M Doses) Figure 19. Global Swine Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 20. Global Swine Vaccines Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Swine Vaccines Sales YoY (2021-2032) & (M Doses) Figure 22. Europe Swine Vaccines Sales YoY (2021-2032) & (M Doses) Figure 23. China Swine Vaccines Sales YoY (2021-2032) & (M Doses) Figure 24. Asia (Excluding China) Swine Vaccines Sales YoY (2021-2032) & (M Doses) Figure 25. South America, Middle East and Africa Swine Vaccines Sales YoY (2021-2032) & (M Doses) Figure 26. Global Swine Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Swine Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Swine Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Swine Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Swine Vaccines Revenue Market Share by Type (2021-2032) Figure 32. Global Swine Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 33. Global Swine Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Swine Vaccines Sales Market Share by Type (2021-2032) Figure 35. Global Swine Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Swine Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Swine Vaccines Revenue Market Share by Application (2021-2032) Figure 38. Global Swine Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 39. Global Swine Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Swine Vaccines Sales Market Share by Application (2021-2032) Figure 41. North America Swine Vaccines Revenue Share by Type (2021-2032) Figure 42. North America Swine Vaccines Sales Share by Type (2021-2032) Figure 43. North America Swine Vaccines Revenue Share by Application (2021-2032) Figure 44. North America Swine Vaccines Sales Share by Application (2021-2032) Figure 45. North America Swine Vaccines Revenue Share by Country (2021-2032) Figure 46. North America Swine Vaccines Sales Share by Country (2021-2032) Figure 47. Europe Swine Vaccines Revenue Share by Type (2021-2032) Figure 48. Europe Swine Vaccines Sales Share by Type (2021-2032) Figure 49. Europe Swine Vaccines Revenue Share by Application (2021-2032) Figure 50. Europe Swine Vaccines Sales Share by Application (2021-2032) Figure 51. Europe Swine Vaccines Revenue Share by Country (2021-2032) Figure 52. Europe Swine Vaccines Sales Share by Country (2021-2032) Figure 53. China Swine Vaccines Revenue Share by Type (2021-2032) Figure 54. China Swine Vaccines Sales Share by Type (2021-2032) Figure 55. China Swine Vaccines Revenue Share by Application (2021-2032) Figure 56. China Swine Vaccines Sales Share by Application (2021-2032) Figure 57. Asia Swine Vaccines Revenue Share by Type (2021-2032) Figure 58. Asia Swine Vaccines Sales Share by Type (2021-2032) Figure 59. Asia Swine Vaccines Revenue Share by Application (2021-2032) Figure 60. Asia Swine Vaccines Sales Share by Application (2021-2032) Figure 61. Asia Swine Vaccines Revenue Share by Country (2021-2032) Figure 62. Asia Swine Vaccines Sales Share by Country (2021-2032) Figure 63. SAMEA Swine Vaccines Revenue Share by Type (2021-2032) Figure 64. SAMEA Swine Vaccines Sales Share by Type (2021-2032) Figure 65. SAMEA Swine Vaccines Revenue Share by Application (2021-2032) Figure 66. SAMEA Swine Vaccines Sales Share by Application (2021-2032) Figure 67. SAMEA Swine Vaccines Revenue Share by Country (2021-2032) Figure 68. SAMEA Swine Vaccines Sales Share by Country (2021-2032) Figure 69. Swine Vaccines Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Swine Vaccines Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • CSF Vaccines
  • FMD Vaccines
  • Porcine Circovirus Vaccines
  • PRRS Vaccines
  • Others
Applications
  • Government Tender
  • Market Sales
Companies covered
  • Merck
  • Boehringer Ingelheim
  • Jinyu Bio-Technology
  • CAHIC
  • Tecon
  • Zoetis
  • Ceva
  • Hile Bio
  • Chopper Biology
  • WINSUN
  • Hipra
  • Ringpu Biology
  • ChengDu Tecbond
  • DHN
  • CAVAC
  • Virbac
  • HVRI
  • Bioveta

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Swine Vaccines Market by Type
  3. 1.2.1 Global Swine Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CSF Vaccines
  5. 1.2.3 FMD Vaccines
  6. 1.2.4 Porcine Circovirus Vaccines
  7. 1.2.5 PRRS Vaccines
  8. 1.2.6 Others
  9. 1.3 Swine Vaccines Market by Application
  10. 1.3.1 Global Swine Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Government Tender
  12. 1.3.3 Market Sales
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Swine Vaccines Market Dynamics
  1. 2.1 Swine Vaccines Industry Trends
  2. 2.2 Swine Vaccines Industry Drivers
  3. 2.3 Swine Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Swine Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Swine Vaccines Revenue by Region
  3. 3.2.1 Global Swine Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Swine Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Swine Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Swine Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Swine Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Swine Vaccines Sales by Region
  9. 3.4.1 Global Swine Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Swine Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Swine Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Swine Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Swine Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Swine Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Swine Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Swine Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Swine Vaccines Sales by Manufacturers
  6. 4.2.1 Global Swine Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Swine Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Swine Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Swine Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Swine Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Swine Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Swine Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Swine Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Swine Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Swine Vaccines Tier 1, Tier 2, and Tier 3
5 Swine Vaccines Market by Type
  1. 5.1 Global Swine Vaccines Revenue by Type
  2. 5.1.1 Global Swine Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Swine Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Swine Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Swine Vaccines Sales by Type
  6. 5.2.1 Global Swine Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Swine Vaccines Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Swine Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Swine Vaccines Price by Type
6 Swine Vaccines Market by Application
  1. 6.1 Global Swine Vaccines Revenue by Application
  2. 6.1.1 Global Swine Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Swine Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Swine Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Swine Vaccines Sales by Application
  6. 6.2.1 Global Swine Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Swine Vaccines Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Swine Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Swine Vaccines Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Swine Vaccines Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Boehringer Ingelheim
  8. 7.2.1 Boehringer Ingelheim Company Information
  9. 7.2.2 Boehringer Ingelheim Business Overview
  10. 7.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
  12. 7.2.5 Boehringer Ingelheim Recent Developments
  13. 7.3 Jinyu Bio-Technology
  14. 7.3.1 Jinyu Bio-Technology Company Information
  15. 7.3.2 Jinyu Bio-Technology Business Overview
  16. 7.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
  18. 7.3.5 Jinyu Bio-Technology Recent Developments
  19. 7.4 CAHIC
  20. 7.4.1 CAHIC Company Information
  21. 7.4.2 CAHIC Business Overview
  22. 7.4.3 CAHIC Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CAHIC Swine Vaccines Product Portfolio
  24. 7.4.5 CAHIC Recent Developments
  25. 7.5 Tecon
  26. 7.5.1 Tecon Company Information
  27. 7.5.2 Tecon Business Overview
  28. 7.5.3 Tecon Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Tecon Swine Vaccines Product Portfolio
  30. 7.5.5 Tecon Recent Developments
  31. 7.6 Zoetis
  32. 7.6.1 Zoetis Company Information
  33. 7.6.2 Zoetis Business Overview
  34. 7.6.3 Zoetis Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Zoetis Swine Vaccines Product Portfolio
  36. 7.6.5 Zoetis Recent Developments
  37. 7.7 Ceva
  38. 7.7.1 Ceva Company Information
  39. 7.7.2 Ceva Business Overview
  40. 7.7.3 Ceva Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ceva Swine Vaccines Product Portfolio
  42. 7.7.5 Ceva Recent Developments
  43. 7.8 Hile Bio
  44. 7.8.1 Hile Bio Company Information
  45. 7.8.2 Hile Bio Business Overview
  46. 7.8.3 Hile Bio Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hile Bio Swine Vaccines Product Portfolio
  48. 7.8.5 Hile Bio Recent Developments
  49. 7.9 Chopper Biology
  50. 7.9.1 Chopper Biology Company Information
  51. 7.9.2 Chopper Biology Business Overview
  52. 7.9.3 Chopper Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Chopper Biology Swine Vaccines Product Portfolio
  54. 7.9.5 Chopper Biology Recent Developments
  55. 7.10 WINSUN
  56. 7.10.1 WINSUN Company Information
  57. 7.10.2 WINSUN Business Overview
  58. 7.10.3 WINSUN Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 WINSUN Swine Vaccines Product Portfolio
  60. 7.10.5 WINSUN Recent Developments
  61. 7.11 Hipra
  62. 7.11.1 Hipra Company Information
  63. 7.11.2 Hipra Business Overview
  64. 7.11.3 Hipra Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hipra Swine Vaccines Product Portfolio
  66. 7.11.5 Hipra Recent Developments
  67. 7.12 Ringpu Biology
  68. 7.12.1 Ringpu Biology Company Information
  69. 7.12.2 Ringpu Biology Business Overview
  70. 7.12.3 Ringpu Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Ringpu Biology Swine Vaccines Product Portfolio
  72. 7.12.5 Ringpu Biology Recent Developments
  73. 7.13 ChengDu Tecbond
  74. 7.13.1 ChengDu Tecbond Company Information
  75. 7.13.2 ChengDu Tecbond Business Overview
  76. 7.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
  78. 7.13.5 ChengDu Tecbond Recent Developments
  79. 7.14 DHN
  80. 7.14.1 DHN Company Information
  81. 7.14.2 DHN Business Overview
  82. 7.14.3 DHN Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 DHN Swine Vaccines Product Portfolio
  84. 7.14.5 DHN Recent Developments
  85. 7.15 CAVAC
  86. 7.15.1 CAVAC Company Information
  87. 7.15.2 CAVAC Business Overview
  88. 7.15.3 CAVAC Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 CAVAC Swine Vaccines Product Portfolio
  90. 7.15.5 CAVAC Recent Developments
  91. 7.16 Virbac
  92. 7.16.1 Virbac Company Information
  93. 7.16.2 Virbac Business Overview
  94. 7.16.3 Virbac Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Virbac Swine Vaccines Product Portfolio
  96. 7.16.5 Virbac Recent Developments
  97. 7.17 HVRI
  98. 7.17.1 HVRI Company Information
  99. 7.17.2 HVRI Business Overview
  100. 7.17.3 HVRI Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 HVRI Swine Vaccines Product Portfolio
  102. 7.17.5 HVRI Recent Developments
  103. 7.18 Bioveta
  104. 7.18.1 Bioveta Company Information
  105. 7.18.2 Bioveta Business Overview
  106. 7.18.3 Bioveta Swine Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Bioveta Swine Vaccines Product Portfolio
  108. 7.18.5 Bioveta Recent Developments
8 North America
  1. 8.1 North America Swine Vaccines Market Size by Type
  2. 8.1.1 North America Swine Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Swine Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Swine Vaccines Price by Type (2021-2032)
  5. 8.2 North America Swine Vaccines Market Size by Application
  6. 8.2.1 North America Swine Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Swine Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Swine Vaccines Price by Application (2021-2032)
  9. 8.3 North America Swine Vaccines Market Size by Country
  10. 8.3.1 North America Swine Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Swine Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Swine Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Swine Vaccines Market Size by Type
  2. 9.1.1 Europe Swine Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Swine Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Swine Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Swine Vaccines Market Size by Application
  6. 9.2.1 Europe Swine Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Swine Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Swine Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Swine Vaccines Market Size by Country
  10. 9.3.1 Europe Swine Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Swine Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Swine Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Swine Vaccines Market Size by Type
  2. 10.1.1 China Swine Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Swine Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Swine Vaccines Price by Type (2021-2032)
  5. 10.2 China Swine Vaccines Market Size by Application
  6. 10.2.1 China Swine Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Swine Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Swine Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Swine Vaccines Market Size by Type
  2. 11.1.1 Asia Swine Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Swine Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Swine Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Swine Vaccines Market Size by Application
  6. 11.2.1 Asia Swine Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Swine Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Swine Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Swine Vaccines Market Size by Country
  10. 11.3.1 Asia Swine Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Swine Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Swine Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Swine Vaccines Market Size by Type
  2. 12.1.1 SAMEA Swine Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Swine Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Swine Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Swine Vaccines Market Size by Application
  6. 12.2.1 SAMEA Swine Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Swine Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Swine Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Swine Vaccines Market Size by Country
  10. 12.3.1 SAMEA Swine Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Swine Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Swine Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Swine Vaccines Value Chain Analysis
  2. 13.1.1 Swine Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Swine Vaccines Production Mode & Process
  6. 13.2 Swine Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Swine Vaccines Distributors
  9. 13.2.3 Swine Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst